Clinical Trial Update: A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update describing the long-term safety and efficacy evaluation of rozanolixizumab in adult participants with ocular myasthenia gravis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Ocular Myasthenia Gravis

Drugs mentioned

• Rozanolixizumab

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Ocular Myasthenia Gravis | Phase 3 | Status: NOT_YET_RECRUITING